Advertisement
Home Tags Prescription Drugs

Tag: Prescription Drugs

Using an anti-inflammatory medicine along with the antiviral drug remdesivir appears to shorten COVID-19 patients' recovery time

Baricitinib May Shorten Recovery Time in Hospitalized COVID-19 Patients

0
Adding anti-inflammatory drug to remdesivir seems to shorten time to hospital discharge
Phototherapy use for psoriasis decreased from 2005 to 2018

Shift Seen to Newer Agents to Treat Psoriasis

0
Biologics and small molecule inhibitors increasingly used for treatment of newly diagnosed psoriasis
In March 2020

Increase Seen in Hydroxychloroquine Rx by Nonroutine Specialists

0
New Rx increased 80-fold among specialists who do not typically prescribe these medications
From 2014 to 2018

Insurer, Insured Costs for HIV PrEP Rising in the United States

0
2014 to 2018 saw increase in estimated third-party, out-of-pocket payments per 30 TDF-FTC tablets
Disease-modifying antirheumatic drug therapy for rheumatoid arthritis treatment also cuts cardiovascular disease risk

Early Therapy for Rheumatoid Arthritis May Slow Heart Disease

0
RA treatment response does not appear to impact improvement in vascular stiffness
For patients with stage III melanoma with BRAF V600E or V600K mutations

Benefit of Adjuvant Dabrafenib + Trametinib Persists in Melanoma

0
Long-term benefit seen for relapse-free survival in stage III disease with BRAF V600E, V600K mutations
Anticholinergic medications are associated with an increased risk for incident mild cognitive impairment and cognitive decline in older adults

Anticholinergic Meds May Raise Risk for Cognitive Decline

0
Effects significantly worse among individuals with risk factors for Alzheimer disease
Some cases of subacute cutaneous lupus erythematosus and systemic lupus erythematosus are drug-induced

Some Lupus Erythematosus Cases Tied to Drug Exposure

0
Cases found for both cutaneous and systemic lupus, but some previous reports due to protopathic bias
For patients with amyotrophic lateral sclerosis

Sodium Phenylbutyrate-Taurursodiol Promising for ALS

0
Slower functional decline seen with active drug versus placebo through 24 weeks
Among patients with heart failure

Empagliflozin Superior to Placebo for Heart Failure

0
Risk for CV death, hospitalization with heart failure reduced, regardless of presence of diabetes